Ubs Group Ag Nutri Band Inc. Call Options Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding NTRB
# of Institutions
21Shares Held
342KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA200KShares$1.36 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA63.6KShares$432,6900.0% of portfolio
-
State Street Corp Boston, MA17.3KShares$117,4080.0% of portfolio
-
Haven Private, LLC Orlando, FL11.5KShares$78,3420.04% of portfolio
-
Northern Trust Corp Chicago, IL11.5KShares$78,0770.0% of portfolio
About NutriBand Inc.
- Ticker NTRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,803,260
- Market Cap $53.1M
- Description
- Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...